REDUCTION OF CHOROIDAL THICKNESS AND CHOROIDAL VASCULARITY INDEX BY FARICIMAB COMPARED WITH RANIBIZUMAB AND AFLIBERCEPT IN POLYPOIDAL CHOROIDAL VASCULOPATHY AND PACHYCHOROID NEOVASCULOPATHY.

چکیده

To evaluate outcomes of intravitreal faricimab in polypoidal choroidal vasculopathy (PCV) and pachychoroid neovasculopathy (PNV), focusing on subfoveal choroidal thickness (SFCT) and choroidal vascularity index (CVI), compared with ranibizumab and aflibercept. This retrospective cohort study…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• تصویربرداری و تشخیص
• درمان های ضد VEGF
• دژنراسیون ماکولا